Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 19:17:5685-5698.
doi: 10.2147/IDR.S483684. eCollection 2024.

Clinical Application of Metagenomic Next-Generation Sequencing (mNGS) in Patients with Early Pulmonary Infection After Liver Transplantation

Affiliations

Clinical Application of Metagenomic Next-Generation Sequencing (mNGS) in Patients with Early Pulmonary Infection After Liver Transplantation

Hua-Bin Peng et al. Infect Drug Resist. .

Abstract

Purpose: To examine the clinical utility of metagenomic next-generation sequencing (mNGS) in individuals with early pulmonary infection following liver transplantation.

Patients and methods: mNGS and traditional detection results were retrospectively collected from 99 patients with pulmonary infection within one week following liver transplantation. These patients were admitted to the Department of Critical Liver Diseases at Beijing Friendship Hospital from February 2022 to February 2024, along with their general clinical data.

Results: mNGS exhibited a significantly higher detection rate than traditional methods (92.93% vs 54.55%, P < 0.05) and was more effective in identifying mixed infections (67.68% vs 14.81%, P < 0.05). mNGS identified 303 pathogens in 92 patients, with Enterococcus faecium, Pneumocystis jirovecii, and human herpesvirus types 5 and 7 being the most prevalent bacteria, fungi, and viruses. A total of 26 positive cases were identified through traditional culture methods (sputum and bronchoalveolar lavage fluid), with 18 cases consistent with mNGS detection results, representing 69.23% consistency. Among the three drug-resistant bacteria that showed positivity in mNGS and traditional culture, the presence of drug-resistance genes-mecA in Staphylococcus aureus; KPC-2, KPC-9, KPC-18, KPC-26, OXA27, OXA423 in Klebsiella pneumoniae; and OXA488 and NDM6 in Pseudomonas aeruginosa-reliably predicted drug-resistance phenotype. The treatment regimen for 76 of the 92 patients with positive mNGS relied on these results; 74 exhibited significant symptom improvement, yielding a 97.37% recovery rate. The overall prognosis was favorable.

Conclusion: mNGS offers rapid detection, a high positivity rate, insensitivity to antibiotics, and a superior ability to detect mixed infections in patients with early post-transplant pulmonary infections. Additionally, mNGS shows good consistency with traditional culture and can predict drug-resistant phenotypes to guide targeted antibiotic therapy for early-stage post-transplant pulmonary infection after liver transplantation. Patients whose antibiotic therapy is based on mNGS results have experienced decreased mortality rates and overall improved prognosis.

Keywords: Clinical value; Liver transplantation; Metagenomic next-generation sequencing; Pulmonary infection.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
The study design of this experiment, the results of conventional tests and metagenomic next-generation sequencing (mNGS), and the patient outcomes after anti-infective therapy were investigated. A total of 99 patients with pulmonary infection within one week after liver transplantation were enrolled in this study. The positive rates of mNGS and traditional detection methods were 92.93% and 54.55%, respectively. Following the anti-infective treatment, 95.96% (95/99) of patients demonstrated improvement.
Figure 2
Figure 2
Pathogen profiles detected via mNGS.
Figure 3
Figure 3
Pathogen spectra detected via traditional detection methods.

Similar articles

References

    1. Reardon LC, Lin JP, VanArsdell GS, et al. Orthotopic heart and combined heart liver transplantation: the ultimate treatment option for failing Fontan physiology. Curr Transplant Rep. 2021;8(1):9–20. doi:10.1007/s40472-021-00315-4 - DOI - PMC - PubMed
    1. Shetty A, Kodali S. Long-term management of the successful adult liver transplant: a patient-friendly summary of the 2012 AASLD and AST practice guideline. Clin Liver Dis (Hoboken) Mar. 2022;19(3):83–88. doi:10.1002/cld.1179 - DOI - PMC - PubMed
    1. Beam E, Razonable RR. A survey of infection prevention and control practices among solid organ transplantation centers. Am J Infect Control Jan. 2019;47(1):101–104. doi:10.1016/j.ajic.2018.06.020 - DOI - PubMed
    1. Guo L, Peng P, Peng WT, Zhao J, Wan QQ. Klebsiella pneumoniae infections after liver transplantation: drug resistance and distribution of pathogens, risk factors, and influence on outcomes. World J Hepatol Apr. 2024;16(4):612–624. doi:10.4254/wjh.v16.i4.612 - DOI - PMC - PubMed
    1. Wu X, Wu L, Wan Q. Pathogen distribution and risk factors of bacterial and fungal infections after liver transplantation. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47(8):1120–1128. doi:10.11817/j.issn.1672-7347.2022.220054 - DOI - PMC - PubMed

LinkOut - more resources